Growth of Global 3D Printed Drugs Market as Forecasted by Research Nester to be on Account of Increasing Number Of 3D Drug Trials 2033

New York, United States, Mon, 31 Jul 2023 06:42:02 / Comserve Inc. / -- The report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the global 3D printed drugs market.

Numerous advantages of 3D printed drugs in comparison to other types of drugs, such as their low cost and better solubility are anticipated to promote the growth of global 3D printed drugs market and help to attain revenue of USD 530 Million by 2033.

The recent market research analysis of “3D Printed Drugs Market: Global Demand Analysis & Opportunity Outlook 2033” by Research Nester delivers an in-depth competitors analysis and a detailed overview of the global 3D printed drugs market in terms of market segmentation by technology, application, end user and by region over the forecast period, i.e., 2023-2033.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the global 3D printed drugs market. These analyses help organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future. Additionally, the growth opportunities exposed by the market is poised to gain significant momentum in the next few years.

Request Report Sample@ https://www.researchnester.com/sample-request-421

3D printed drugs market to find numerous growth opportunities on the back of growing number of diseases among children and elderly people, finds Research Nester

The global 3D printed drugs market is estimated to grow majorly on account of the rising incidence of chronic diseases, huge base of geriatric population, rising cases of infectious diseases among children along with technological advancements and a rapid rise in noncommunicable diseases worldwide. Approximately 74% of all deaths worldwide are caused by noncommunicable diseases (NCDs). NCDs cause 17 million premature deaths every year; 86% of these deaths take place in low-income and middle-income countries.

The global 3D printed drugs market is segmented on the basis of technology into inkjet printing, zipdose technology, and stereolithography. The zipdose technology is to garner the highest revenue by the end of 2033 by growing at a significant CAGR over the forecast period backed by increasing dysphagia cases. Among hospitalized patients, dysphagia was observed to be prevalent in 15% to 17% of cases. There is an estimated 31% to 59% prevalence of dysphagia among nursing home residents. This device facilitates swallowing drugs and proves effective for patients with dysphagia in addition to being easy to use. Furthermore, geriatric and pediatric patients' increasing demand for rapidly dispersible drugs is expected to boost segment growth.

By region, the North America 3D printed drugs market is to generate the highest revenue by the end of 2033. This growth is anticipated by increasing chronic disease incidence and health awareness among the population. Approximately 132 million Americans suffer from at least one chronic illness, which is 44% of the population. Chronic diseases cause more than 1.6 million deaths annually in the United States. Moreover, the region's well-developed healthcare infrastructure, extensive research and development activities, and technological innovations are projected to drive the regional market growth.

The research is global in nature and covers detailed analysis on the 3D printed drugs market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising of global 3D printed drugs market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

This report also provides the existing competitive scenario of some of the key players of the global 3D printed drugs market which includes company profiling of Extend Biosciences, Bioduro, Affinity Therapeutics, Osmotica Pharmaceuticals, Acrux, Thiomatrix, Ico Therapeutics Inc., Formac Pharmaceuticals, BiopharmX and Pacira Pharmaceuticals Inc., and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global 3D printed drugs market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.     

Purchase Copy of this Report@ https://www.researchnester.com/purchage/purchase_product.php?token=421

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

For more information, please contact:

Research Nester
Email: [email protected]
Tel: +1 646 586 9123

The post Growth of Global 3D Printed Drugs Market as Forecasted by Research Nester to be on Account of Increasing Number Of 3D Drug Trials 2033 appeared first on Comserveonline.